ADCOCK INGRAM HOLDINGS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.78 ZAR | +4.76% |
|
+5.15% | -5.52% |
| Feb. 21 | Adcock Ingram Holdings Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
| Feb. 21 | Transcript : Adcock Ingram Holdings Limited, H1 2024 Earnings Call, Feb 21, 2024 |
| Sales 2024 * | 9.61B 511M | Sales 2025 * | 10.18B 541M | Capitalization | 8.38B 445M |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.92 x |
| Net Debt 2024 * | 421M 22.37M | Net Debt 2025 * | 86.37M 4.59M | EV / Sales 2025 * | 0.83 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
| Yield 2024 * |
3.97% | Yield 2025 * |
4.22% | Free-Float | 34.64% |
More Fundamentals
* Assessed data
More news
Latest transcript on Adcock Ingram Holdings Limited
More press releases
| 1 day | +4.76% | ||
| 1 week | +5.15% | ||
| 1 month | +1.96% | ||
| 3 months | +1.23% | ||
| 6 months | +4.74% | ||
| Current year | -5.52% |
1 week
53.79
56.78
1 month
52.6760.00
Current year
51.1560.60
1 year
50.3061.48
3 years
40.6561.48
5 years
37.0067.96
10 years
35.4472.00
| Managers | Title | Age | Since |
|---|---|---|---|
Andrew Hall
CEO | Chief Executive Officer | 62 | 07-08-31 |
Ridwan Essa
DFI | Director of Finance/CFO | - | 07-01-31 |
| Director of Finance/CFO | - | 07-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Busisiwe Mabuza
BRD | Director/Board Member | 60 | 22-08-31 |
Claudia Manning
BRD | Director/Board Member | 56 | 16-11-23 |
Andrew Hall
CEO | Chief Executive Officer | 62 | 07-08-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 4 M€ | -4.41% | - | |
| 0.00% | 112 M€ | +4.61% | - | |
| 0.00% | 34 M€ | +3.86% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 56.78 | +4.76% | 257,219 |
| 24-05-30 | 54.2 | -1.45% | 332,091 |
| 24-05-28 | 55 | +0.92% | 63,659 |
| 24-05-27 | 54.5 | +0.93% | 3,683 |
| 24-05-24 | 54 | -0.46% | 53,500 |
End-of-day quote Johannesburg S.E., May 30, 2024
More quotes
Adcock Ingram Holdings Limited is one of South Africa's largest pharmaceutical groups. The group also provides hospital products. Net sales break down by family of products as follows:
- pharmaceutical products (79.2%): OTC medicines, prescription products, etc.;
- hospital products (20.8%; No. 1 in South Africa).
At the end of June 2023, the group had 3 production sites located in South Africa.
France accounts for 98.6% of net sales.
Sector
Pharmaceuticals
Calendar
2024-08-20
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
56.78
ZAR
Average target price
56
ZAR
Spread / Average Target
-1.37%
Chiffre d''affaires - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.52% | 445M | |
| +15.91% | 41.97B | |
| +22.40% | 22.34B | |
| +18.48% | 15.25B | |
| +16.12% | 14B | |
| +45.12% | 12.06B | |
| -9.58% | 6.8B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +14.18% | 5.49B |
- Stock Market
- Equities
- AIP Stock
